@article {1910, title = {Nano Transdermal Delivery Potential of Fucoidan from Sargassum sp. (Brown Algae) as Chemoprevention Agent for Breast Cancer Treatment}, journal = {Pharmacognosy Journal}, volume = {14}, year = {2022}, month = {December 2022}, pages = {789-795}, type = {Research Article }, chapter = {789}, abstract = {

Conventional chemotherapy substances are associated with mild to severe side effects that affect both healthy and cancer cells. It is presumed to improve therapeutic efficacy in coexistence reducing chemotherapy{\textquoteright}s side effects. Fucoidan is an anticancer bioactive compound derived from Sargassum sp. that has low cytotoxic activity. The purpose of this study was to explore the effectiveness of anticancer activities of fucoidan from Sargassum sp. against breast cancer then analyze the suitability of nano transdermal patch of fucoidan and blueprint the long-term research design of nano transdermal patch as a chemoprevention agent in the chemotherapeutic management of breast cancer. This research was performed through a literature study and in silico study by imposing carbonic anhydrase IX (CA IX) as a marker of hypoxia and metastatic state of cancer cells. The results showed that the fucoidan from Sargassum sp. effectively induced apoptosis and prevented metastasis of breast cancer cells through the Bcl-2, Bcl-w, and bad pathways. Fucoidan, in addition, was predicted to inhibit CA IX by Glu4 Glu5, Leu7, Pro8, and Asp6 residues. Therefore, the delivery of fucoidan is favored to have a local effect on the site of breast cancer cells by nano transdermal patch preparations using fucoidan nanoparticle polymer. Further nano transdermal patch development as a treatment for breast cancer is suggested through the stages of formulation optimization, optimum formula activity testing, patent filing, and distribution in health services.

}, keywords = {Anticancer, Breast cancer, Fucoidan, Nano transdermal, Sargassum sp. .}, doi = {10.5530/pj.2022.14.169}, author = {Syeftyan Muhammad Ali Hamami and Michelle Fai and Ahmad Fariduddin Aththar and M Nizam Zulfi Zakaria and Viol Dhea Kharisma and Ahmad Affan Ali Murtadlo and Muhammad Badrut Tamam and Vikash Jakhmola and Muhammad Hermawan Widyananda and Dora Dayu Rahma Turista and Maksim Rebezov and Nikolai Maksimiuk and Nataliya Kulmakova and Evgeniya Latynina and ANM Ansori and Rahadian Zainul and Riso Sari Mandeli and Devi Purnamasari and Oski Illiandri and Khoirun Nisyak and Ernarisa Fitri} } @article {1196, title = {Modern Approaches to the Analysis of Kelp (Laminaria sp.) as Pharmacopoeial Herbal Drugs and Food Products}, journal = {Pharmacognosy Journal}, volume = {12}, year = {2020}, month = {June 2020}, pages = {929-937}, type = {Review Article}, chapter = {929}, abstract = {

Background: Currently, the chemical composition of Laminaria J.V. Lamour. species is well studied; they have found applications in the food, cosmeceutical and pharmaceutical industries. The main groups of biologically active compounds are polysaccharides (alginic acid, laminarin, mannitol, fucoidan, and others) and minerals (iodine compounds, magnesium, potassium, calcium, iron) that are determined according to pharmacopoeial and All-Union State Standards requirements. Materials and Methods: For data obtaining various types of search tools and engines such as Google, Google scholar, scientific literature (including Russian sources), normative documentation of Russian Federation (State Pharmacopoeia of Russian Federation IV edition, All-Union State Standards, and others) electronic databases such as e-Library, Scopus, Web of Science, Pubmed were used. Results: In the course of this review study, a modern characteristic of the kelp thallus as a pharmaceutical, cosmeceutical, food substance of plant origin is presented. The data on the chemical composition, harvesting, and processing of raw materials are summarized. The standardization and safety issues of kelp thallus are considered taking into account modern pharmacopoeial and food international requirements. The approaches to the qualitative and quantitative analysis of biologically active compounds (polysaccharides, iodine) and the determination of safety indicators are studied. Conclusions: The regulatory documentation that is used in the quality control of kelp needs to be finalized and updated. For pharmacopoeial analysis, all possible physicochemical methods (gravimetric, titrimetric, spectrophotometric) should be presented in the newly approved monograph. In this case, modern procedures should be developed, including HPLC with various types of detection (determination of the carbohydrates profile and polysaccharides, including methods with acid and enzyme hydrolysis). This will ensure the required level of quality, the safety of kelp (Laminaria) raw materials.

}, keywords = {alginic acid, Fucoidan, Iodine, Kelp, Laminaria japonica, Laminaria saccharina, Laminarin, Mannitol}, doi = {10.5530/pj.2020.12.132}, author = {Bokov DO and Potanina OG and Nikulin AV and Shchukin VM and Orlova VA and Bagirova GB and Kakhramanova SD and Al- Khafaji H and Balobanova NP and Evgrafov AA and Samylina IA and Krasnyuk II and Golubeva OA and Kuleshova ES and Moiseev DV and Bessonov VV} } @article {219, title = {Cytotoxicity of Fucoidan from Three Tropical Brown Algae Against Breast and Colon Cancer Cell Lines}, journal = {Pharmacognosy Journal}, volume = {9}, year = {2017}, month = {December 2016}, pages = {14-20}, type = {Original Article}, chapter = {14}, abstract = {

Introduction: Fucoidan is a sulfated polysaccharide that has a wide range of bioactivities including anti-cancer. This polysaccharide commonly is extracted from marine brown seaweed. There is lack of information on the fucoidan extracted from tropical brown algae and its anti-cancer activity. Objectives: The objectives of this study were to purify fucoidan from Sargassum sp., Turbinaria sp. and Padina sp., and to evaluate their cytotoxicity against breast cancer (MCF-7) and colon cancer cells (WiDr). Materials and Methods: Fucoidan extraction was conducted by using acid extraction method. Purified fucoidans were obtained by DEAE cellulose column chromatography and confirmed by HPLC and FT-IR spectrometry. The cytotoxicity was evaluated by using the MTT (3-[4,5-dimethylthiazol-2-yl] -2,5- diphenyltetrazolium bromide) assay. Results: Fucoidan from Sargassum sp. and Turbinaria sp. showed low cytotoxicity with IC50 ranging between 461-663 \μg/mL. Higher cytotoxicity against MCF-7 and WiDr was showed by fucoidan from Padina sp. with IC50 of 144 and 118 \μg/mL, respectively. While its IC50 against Vero cells was 501 \μg/mL.Standard fucoidan from Fucus vesiculosus exhibited IC50 of 60, 63 and 211 \μg/mL against MCF-7, WiDr and Vero Cells, respectively. Although the IC50 was higher than that of standard fucoidan, Padina sp. fucoidan showed cytotoxicity comparable with standard fucoidan at concentrations below 100 \μg/mL. Conclusion: These results indicated that Padina sp.fucoidan showed potential selective cytotoxicity, and promising for the development of an anti-cancer compound.

}, keywords = {Breast cancer, Colon cancer, Cytotoxicity., Fucoidan, Phaeophyta}, doi = {10.5530/pj.2017.1.3}, author = {Alim Isnansetyo and Fadilah Nor Laili Lutfia and Muhammad Nursid and Trijoko and Ratna Asmah Susidarti} }